Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029
Notice Number:

Key Dates

Release Date:

July 6, 2022

Response Date:
November 30, 2022

Related Announcements


Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)




The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. NIAMS is updating its Strategic Plan to help guide the research it supports over the next 5 years. The new Plan will focus on cross-cutting thematic research opportunities where the Institute can be best positioned to make a difference in the lives of all Americans. Public input on these cross-cutting themes and on bold aspirations that the research community is poised to accomplish is a crucial initial step in this effort. NIAMS staff, leadership, and Advisory Council members will review and consider input received in response to this RFI as the Institute moves forward to develop its Strategic Plan.

Information Requested

Through this RFI, NIAMS invites feedback from researchers in academia and industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, Federal agencies, and other interested members of the public. Professional societies and patient organizations are strongly encouraged to submit a single response that reflects the views of their membership as a whole.

Please provide your perspective on the following issues:

  • Cross-cutting thematic research opportunities that the Institute should commit to addressing in fiscal years 2025-2029. Please include the anticipated impacts on scientific knowledge, the research community, or human health in your response.
  • Bold aspirations that NIAMS-supported research could accomplish over the next half-decade.

How to Submit a Response

Responses to this RFI must be submitted electronically at

Responses must be received by November 30, 2022.

Responses to this RFI are voluntary. Do not include any proprietary, classified, confidential, trade secret, or sensitive information in your response. The responses will be reviewed by NIAMS staff, leadership, and Advisory Council members. Individual feedback will not be provided to any responder. NIAMS will use the information submitted in response to this RFI at its discretion and will not provide comments to any responder’s submission. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government reserves the right to use any submitted information on public NIH websites, in reports, in summaries of the state of the science, in any possible resultant solicitation(s), grant(s), or cooperative agreement(s), or in the development of future funding opportunity announcements.

This RFI is for information and planning purposes only and shall not be construed as a solicitation, grant, or cooperative agreement, or as an obligation on the part of the Federal Government, the NIH, or individual NIH Institutes and Centers to provide support for any ideas identified in response to it. The Government will not pay for the preparation of any information submitted or for the Government’s use of such information. No basis for claims against the U.S. Government shall arise as a result of a response to this request for information or from the Government’s use of such information.

We look forward to your input and hope that you will share this RFI document with your colleagues.



Please direct all inquiries to:

Jonelle K. Drugan, Ph.D., M.P.H.
Co-Acting Branch Chief
Scientific Planning, Policy, and Analysis Branch
IC Name: National Institute of Arthritis and Musculoskeletal and Skin Diseases
Telephone: 301-496-8271